Benzinga | Sep 27, 2021 04:06PM EDT

AstraZeneca, Sputnik Light COVID-19 Vaccine Mix Shows Strong Antibody Growth: Reuters

* A small-scale study of AstraZeneca Plc (NASDAQ:AZN) COVID-19 combined with Sputnik Light vaccines has shown robust antibody growth in most of the study's participants, citing the Russian Direct Investment Fund Reuters reported.

* The data was collected from 20 people who took part in a 100-person study in Azerbaijan in February.

* They first received the AstraZeneca shot followed by the one-dose Russian-made Sputnik Light shot 29 days later, RDIF said.

* "According to the results of the interim analysis, a fourfold or higher increase in neutralizing antibodies to the spike protein (S-protein) of the SARS-CoV-2 was found in 85% of the volunteers on the 57th day of the study," RDIF said.

* Price Action: AZN stock closed down 2.70% at $58.72 on Monday.

* Photo by torstensimon from Pixabay